Cellectis Announces Presentations at Upcoming Conferences
Publié le 30 novembre 2015
New York, November 30, 2015 – Cellectis (Alternext: ALCLS – Nasdaq: CLLS), on developing immunotherapies based on gene edited CAR-T cells (UCART), today announced presentations at the Piper Jaffray 27th Annual Healthcare Conference and the Oppenheimer 26th Annual Healthcare Conference.
• December 2, 2015 - Piper Jaffray 27th Annual Healthcare Conference - NYC
Fireside chat presentation from 1:00pm to 1:25pm ET at the New York Palace Hotel
• December 9, 2015 - Oppenheimer 26th Annual Healthcare Conference -NYC
Company presentation from 9:10am to 9:40am ET at the Westin New York Grand Central